CaMKII and GLUT1 in heart failure and the role of gliflozins
Author:
Funder
Deutsche Forschungsgemeinschaft
Universitätsklinikum Regensburg
Publisher
Elsevier BV
Subject
Molecular Biology,Molecular Medicine
Reference136 articles.
1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N. Engl. J. Med.,2015
2. Dapagliflozin in patients with heart failure and reduced ejection fraction;McMurray;N. Engl. J. Med.,2019
3. How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial;Inzucchi;Diabetes Care,2018
4. Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes;Mustroph;ESC Heart Fail.,2018
5. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members;Chen;Diab. Ther.,2010
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods;Biomedicine & Pharmacotherapy;2024-08
2. CaMK II in Cardiovascular Diseases, Especially CaMK II-δ: Friends or Enemies;Drug Design, Development and Therapy;2024-08
3. The Off-Target Cardioprotective Mechanisms of Sodium–Glucose Cotransporter 2 Inhibitors: An Overview;International Journal of Molecular Sciences;2024-07-14
4. Empagliflozin inhibits increased Na influx in atrial cardiomyocytes of patients with HFpEF;Cardiovascular Research;2024-05-10
5. Role of CaMKII in diabetes induced vascular injury and its interaction with anti-diabetes therapy;Reviews in Endocrine and Metabolic Disorders;2023-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3